Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Safety and Longer-Term Efficacy of Concizumab Prophylaxis in Patients with Hemophilia a or b with Inhibitors: Results from the Extension Part of the Phase 2 explorer4 Trial

Amy D Shapiro, MD, Giancarlo Castaman, MD, Katarina Cepo, MD, Sidsel Marie Tønder, MSc, Tadashi Matsushita, MD PhD, Lone Hvitfeldt Poulsen, Guy Young, MD, Silva Zupancic-Šalek, MD, Victor Jimenez Yuste, MD PhD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-139910

Published: 2020

Journal Articles

Extended-Interval Prophylaxis with rFIXFc in Adults and Adolescents with Hemophilia B: Interim Results of the B-YOND Extension Study

Johnny Mahlangu, Amy D Shapiro, MD, K John Pasi, Margaret V Ragni, Margareth Castro Ozelo, MD PhD, Johannes Oldenburg, Tadashi Matsushita, MD PhD, Ross I Baker, MD, Huixing Yuan, Alejandra Ramirez-Santiago, Glenn F Pierce, Geoffrey Allen, Baisong Mei

Blood (2015) 126 (23): 1088.

https://doi.org/10.1182/blood.V126.23.1088.1088

Published: 2015

Journal Articles

Genetic Analysis of Von Willebrand Disease By Using the Exome Sequencing Approach

Naomi Sanda, Msc, Nobuaki Suzuki, MD PhD, Takeshi Kanematsu, MD, Mika Ogawa, MD, Mayuko Kishimoto, MD PhD, Shigeo Nakamura, MD PhD, Tadashi Matsushita, MD PhD

Blood (2015) 126 (23): 1097.

https://doi.org/10.1182/blood.V126.23.1097.1097

Published: 2015

Journal Articles

Clinical Course and Management of Surgical Emergency in a Severe Hemophilia a Patient Under Weekly Subcutaneous Administration of a Bispecific Antibody to Factors IXa and X (ACE910)

Takeshi Kanematsu, MD, Nobuaki Suzuki, MD PhD, Naomi Sanda, MSc, Mika Ogawa, MD, Mayuko Kishimoto, MD PhD, Atsuo Suzuki, PhD, Hitoshi Kiyoi, MD PhD, Ryu Kasai, MSc, Tadashi Matsushita, MD PhD

Blood (2015) 126 (23): 1099.

https://doi.org/10.1182/blood.V126.23.1099.1099

Published: 2015

Journal Articles

An Integrated Analysis of Long Term Safety of an Extended Half-Life, Pegylated, Full-Length Recombinant Factor VIII (BAX 855) in the Treatment of Hemophilia a

Pratima Chowdary, Barbara Konkle, MD, Tadashi Matsushita, MD PhD, Werner Engl, Lisa Patrone, Brigitt E. Abbuehl

Blood (2015) 126 (23): 3522.

https://doi.org/10.1182/blood.V126.23.3522.3522

Published: 2015

Journal Articles

Outcome of the Japanese Immune Tolerance Induction (ITI) Registry and Predictors of Successful ITI

Keiji Nogami, MD PhD, Masashi Taki, MD PhD, Tadashi Matsushita, MD PhD, Shouichi Ohga, MD PhD, Hideji Hanabusa, Toshiaki Oka, MD, Yasuo Horikoshi, MD, Kagehiro Amano, MD PhD, Midori Shima, MD PhD

Blood (2015) 126 (23): 3526.

https://doi.org/10.1182/blood.V126.23.3526.3526

Published: 2015

Journal Articles

Safety and Prophylactic Efficacy Profiles of ACE910, a Humanized Bispecific Antibody Mimicking the FVIII Cofactor Function, in Japanese Hemophilia A Patients Both without and with FVIII Inhibitors: First-in-Patient Phase 1 Study

Midori Shima, MD PhD, Hideji Hanabusa, MD, Masashi Taki, MDPhD, Tadashi Matsushita, MD PhD, Tetsuji Sato, MD, Katsuyuki Fukutake, MD PhD, Naoki Fukazawa, Shingo Maisawa, Koichiro Yoneyama, Keiji Nogami, MD PhD

Blood (2014) 124 (21): 691.

https://doi.org/10.1182/blood.V124.21.691.691

Published: 2014

Journal Articles

Establishment of Blood Outgrowth Endothelial Cells from a Type 3 Von Willebrand Disease (VWD) Patient with a Neutralizing Anti-VWF Inhibitors

Naomi Sanda, MSc, Nobuaki Suzuki, MD PhD, Mayuko Kishimoto, MD, Natsumi Kameyama, Yoko Kajiura, Hiroyuki Matsumoto, Shigeo Nakamura, MD PhD, Tadashi Matsushita, MD PhD

Blood (2014) 124 (21): 1508.

https://doi.org/10.1182/blood.V124.21.1508.1508

Published: 2014

Journal Articles

Thrombomodulin Alfa Treatment For Disseminated Intravascular Coagulation In Acute Promyelocytic Leukemia: A Retrospective Analysis Of The Open-Label, Multicenter Study Cohort

Tadashi Matsushita, MD, PhD, Jyunichi Watanabe, Goichi Honda, PhD, Jun Mimuro, MD, PhD, Hoyu Takahashi, MD, PhD, Hajime Tsuji, MD, PhD, Yutaka Eguchi, MD, PhD, Isao Kitajima, MD, PhD, Yoichi Sakata, MD, PhD

Blood (2013) 122 (21): 2391.

https://doi.org/10.1182/blood.V122.21.2391.2391

Published: 2013

Journal Articles

Evaluation of the Safety, Efficacy of Recombinant Factor IX (nonacog alfa) in Japanese Patients with Hemophilia B- Interim Result of Post Marketing Surveillance Study -

Takashi Suzuki, MD, PhD, Katsuyuki Fukutake, MD, PhD, Kagehiro Amano, MD, PhD, Hideji Hanabusa, MD, Masashi Taki, MD, PhD, Tadashi Matsushita, MD, PhD, Midori Shima, MD, PhD, Michio Sakai, MD, PhD, Masahiro Iizuka, Yoshiyuki Shibasaki

Blood (2012) 120 (21): 3378.

https://doi.org/10.1182/blood.V120.21.3378.3378

Published: 2012

Journal Articles

RhoH Downregulates Rac Through RhoGAP Family Protein

Akira Katsumi, MD, PhD, Miki Kobayashi, MD, PhD, Tadashi Matsushita, MD, PhD, Hitoshi Kiyoi, MD, PhD, Tetsuhito Kojima, MD, PhD, Mitsuo Maruyama, PhD, Kozo Kaibuchi, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2011) 118 (21): 4792.

https://doi.org/10.1182/blood.V118.21.4792.4792

Published: 2011

Journal Articles

Clinicopathological Features of Nodular Sclerosis-Type Classical Hodgkin Lymphoma In the Elderly: Multicenter Study of Hodgkin Lymphoma In Japan

Naoko Asano, MD, Tomohiro Kinoshita, MD, PhD, Koichi Ohshima, MD, Tadashi Yoshino, MD, Nozomi Niitsu, MD, Norifumi Tsukamoto, MD, PhD, Kaoru Hirabayashi, MD, Koji Izutsu, MD, Yasuo Morishima, MD, PhD, Tadashi Matsushita, MD, PhD, Shigeo Nakamura, MD

Blood (2010) 116 (21): 2677.

https://doi.org/10.1182/blood.V116.21.2677.2677

Published: 2010

Journal Articles

R702C Mutation of the MYH9 Gene Provokes Impaired Platelet Formation, Renal Focal Segmental Glomerulosclerosis, and Hearing Disability In the Mice Model

Nobuaki Suzuki, Shinji Kunishima, PhD, Makoto Ikejiri, Shoichi Maruyama, MD, PhD, Michihiko Sone, MD, PhD, Akira Takagi, Kanji Hirashima, Masahito Ikawa, Masaru Okabe, Tetsuhito Kojima, MD, PhD, Hidehiko Saito, MD, Tomoki Naoe, MD, PhD, Tadashi Matsushita, MD, PhD

Blood (2010) 116 (21): 482.

https://doi.org/10.1182/blood.V116.21.482.482

Published: 2010

Journal Articles

αvβ3 Integrin Activation and Matrix Binding Mediate Cellular Responses to Mechanical Stretch.

Akira Katsumi, MD, PhD, Tadashi Matsushita, MD, PhD, Tomoki Naoe, MD, PhD, Martin A. Schwartz, PhD

Blood (2005) 106 (11): 3689.

https://doi.org/10.1182/blood.V106.11.3689.3689

Published: 2005

Journal Articles

Anti-HCV Agent, Ribavirin, Decreases Events of Bleeding in Hemophilia Patients, Possibly by Elevating the Clotting Activity of Factor VII.

Koji Yamamoto, MD, PhD, Takashi Honda, MD, Satoshi Suzuki, Hidenori Toyoda, MD, Tadashi Matsushita, MD, PhD, Tetsuhito Kojima, MD, PhD, Hidemi Goto, MD, Junki Takamatsu, MD

Blood (2005) 106 (11): 3214.

https://doi.org/10.1182/blood.V106.11.3214.3214

Published: 2005

Journal Articles

The Stress-Induced PAI-1 Expression Is Enhanced in Obese Mice: A Possible Mechanism of Stress-Associated Thrombosis in Obese Subjects.

Koji Yamamoto, MD, PhD, Tetsuhito Kojima, MD, Tatsuya Adachi, MD, Mutsuharu Hayashi, MD, Tadashi Matsushita, MD, Junki Takamatsu, MD, David J. Loskutoff, PhD, Hidehiko Saito, MD

Blood (2004) 104 (11): 2984.

https://doi.org/10.1182/blood.V104.11.2984.2984

Published: 2004

NARROW

Safety and Longer-Term Efficacy of Concizumab Prophylaxis in Patients with Hemophilia a or b with Inhibitors: Results from the Extension Part of the Phase 2 explorer4 Trial

Extended-Interval Prophylaxis with rFIXFc in Adults and Adolescents with Hemophilia B: Interim Results of the B-YOND Extension Study

Genetic Analysis of Von Willebrand Disease By Using the Exome Sequencing Approach

Clinical Course and Management of Surgical Emergency in a Severe Hemophilia a Patient Under Weekly Subcutaneous Administration of a Bispecific Antibody to Factors IXa and X (ACE910)

An Integrated Analysis of Long Term Safety of an Extended Half-Life, Pegylated, Full-Length Recombinant Factor VIII (BAX 855) in the Treatment of Hemophilia a

Outcome of the Japanese Immune Tolerance Induction (ITI) Registry and Predictors of Successful ITI

Safety and Prophylactic Efficacy Profiles of ACE910, a Humanized Bispecific Antibody Mimicking the FVIII Cofactor Function, in Japanese Hemophilia A Patients Both without and with FVIII Inhibitors: First-in-Patient Phase 1 Study

Establishment of Blood Outgrowth Endothelial Cells from a Type 3 Von Willebrand Disease (VWD) Patient with a Neutralizing Anti-VWF Inhibitors

Thrombomodulin Alfa Treatment For Disseminated Intravascular Coagulation In Acute Promyelocytic Leukemia: A Retrospective Analysis Of The Open-Label, Multicenter Study Cohort

Evaluation of the Safety, Efficacy of Recombinant Factor IX (nonacog alfa) in Japanese Patients with Hemophilia B- Interim Result of Post Marketing Surveillance Study -

RhoH Downregulates Rac Through RhoGAP Family Protein

Clinicopathological Features of Nodular Sclerosis-Type Classical Hodgkin Lymphoma In the Elderly: Multicenter Study of Hodgkin Lymphoma In Japan

R702C Mutation of the MYH9 Gene Provokes Impaired Platelet Formation, Renal Focal Segmental Glomerulosclerosis, and Hearing Disability In the Mice Model

αvβ3 Integrin Activation and Matrix Binding Mediate Cellular Responses to Mechanical Stretch.

Anti-HCV Agent, Ribavirin, Decreases Events of Bleeding in Hemophilia Patients, Possibly by Elevating the Clotting Activity of Factor VII.

The Stress-Induced PAI-1 Expression Is Enhanced in Obese Mice: A Possible Mechanism of Stress-Associated Thrombosis in Obese Subjects.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only